J. Kaneko

Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial

G. Sobue, K. Hirata, K. Kaida, 2018, The Lancet Neurology.

Safety of tapering tacrolimus dose in patients with well‐controlled anti‐acetylcholine receptor antibody‐positive myasthenia gravis

M. Sonoo, A. Uzawa, J. Nakahara, 2020, European journal of neurology.

Cryptogenic NORSE

Hiroki Asari, Y. Ugawa, A. Kosakai, 2017, Neurology: Neuroimmunology & Neuroinflammation.